SIMULTANEOUS EVALUATION OF ABACAVIR SULFATE AS WELL AS LAMIVUDINE IN MEDICAL FORMULATIONS BY GRADIENT REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY TECHNIQUE
DOI:
https://doi.org/10.22159/ajpcr.2018.v11s4.31708Keywords:
Abacavir sulfate, Lamivudine, Reversed-phase high-performance liquid chromatography, Validation, Simultaneous estimation, ICH guidelines, Pharmaceutical dosage formsAbstract
Objective: A precise, accurate, simple, and gradient reversed-phase high-performance liquid chromatography (HPLC) method was adapted for the determination of abacavir sulfate (ABV) in combination with lamivudine (LMV) having tablet formulations simultaneously. This method developed has been validated as per the guidelines of ICH.
Method: Waters HPLC has been used in the method with a column named Zorbax C18 with the dimensions as 4.6 nm×150 mm, 3.5 μm. Phosphate buffer (PH - 3.9) was used as Eluent - A, Eluent - B was methanol, and water and methanol (50:50 v/v) were utilized as diluents. The rate of flow was 1.5 ml/min.
Results: The wavelength of detection has been detected at about 270 nm. Linearity ranges of ABV and LMV were 88–266 μg/ml and 38–116 μg/ml, respectively. Retention times of ABV (3.66 min) and LMV (10.71 min) were determined. The values of the study of percentage recovery of ABV and LMV were determined to be within 98.3–99.2%.
Conclusion: The estimation of ABV and LMV in all pharmaceutical dosage forms could be performed successfully by employing this method.
Downloads
References
Sudha T, Saminathan J, Anusha K, Keerthi M, Bhargavi Y, Ganesan.V. Simultaneous UV spectrophotometric estimation of lamivudine And abacavir sulphate in bulk and in tablet dosage form. J Chem Pharm Res 2010;2:45-51.
Nagulwar PV, Kishor BP. Simultaneous estimation of abacavir, lamivudine and zidovudine in combined tablet dosage form by UV spectrophotometric method. J Chem Pharm Res 2011;2:610-14.
Kumar BR, Priyanka M, Priyamvada BN, Prasad K, Mallikarjuna K, Anuradha B. Method development and validation for the determination of abacavir and lamivudine by using RP-HPLC in pure and pharmaceutical dosage form. Int J Pharm World Res 2012;3:2-3.
Sudha T, Kumar VR, Hemalatha PV. RP-HPLC method for the simultaneous estimation of lamivudine and abacavir sulphate in tablet dosage form. Int J Pharm Biol Res 2010;1:108-13
Nagulwar PV, Kishor BP. Development of RP-HPLC method for the simultaneous estimation of abacavir and lamivudine in combined tablet dosage form. Int J Pharm Appl 2012;3:293-6.
Mohideen S, Kumar GV, Surendranath Y, Kumar PS, Krishnan SN. Validated RP-HPLC for simultaneous estimation of abacavir and lamivudine in tablet dosage form. Int J Pharm Pharm Sci 2012;4:349 56.
Sudha T, Raviumar VR, Hemalatha PV. Validated HPTLC method for simultaneous determination of lamivudine and abacavir sulphate in tablet dosage form. Int J Pharm Sci Res 2012;1:107-11.
Kumar AP, Parthasarathi G, Sudheer AP, Mothi SN, Swamy VH, Rao S. Incidence and risk factors of renal impairment in HIV-1 infected patients receiving tenofovir based antiretroviral therapy in a South Indian hospital. Int J Pharm Pharm Sci 2017;9:152-5.
Wolf E, Blankenburg M, Bogner JR, Becker W, Gorriahn D, Mueller MC, et al. Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany. Eur J Med Res 2010;15:145-51.
Kauf TL, Farkouh RA, Earnshaw SR, Watson ME, Maroudas P, Chambers MG, et al. Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV. Pharmacoeconomics 2010;28:1025-39.
Kubaeva MB, Sh SH, Loskutova EE. Cost-effectiveness of Hla-B*5701 prospective genetic screening of hypersensitivity to abacavir.
Asian J Pharm Clin Res 2018;11:281-3.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
